team - very strong team
mvp - yes
idea - interesting
competitors - low
market - #medicine
Dec 8th 2017
3 months ago
Feb 28th 2018
in 3 days
The LUVEN screening test method created by the scientist of our company detects cancer at its early stages with the accuracy of up to 96% only comparable to biopsy. None of the existing diagnostic techniques has such a high diagnostic accuracy.
The LUVEN technology allows to diagnose the disease at its early stages, thus, giving a chance to thousands of people to prevent its further development.
For more than 20 years the Ukrainian scientists have been developing a diagnostic method based on cyto-morphological and cyto-biophysical properties of the buccal epithelial cells. In 2004 at Fenix Cancer Research Center, they continued their research and, finally, came up and implemented an experimental method.
A new method of biomaterial analysis allowed to establish a cancer diagnosis at its early stages and to assess predisposition to cancer .A great success in this medical field opened a door to new possibilities, including cancer prevention and therapy.
The longstanding scientific research in this field culminated in development of The Luven diagnostic system.